Pulmonary non-tuberculous mycobacterial infection in congenital contractural arachnodactyly

International Journal of Tuberculosis and Lung Disease

Volumn 16, Issue 4, 2012, Pages 561-563

  Paulson, Michelle L ^a,b   Olivier, K N ^b   Holland, S M ^b  

^a SAIC FREDERICK INC   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Atypical mycobacterial; Fibrillin; Human fibrillin 2 (congenital contractural arachnodactyly) protein; Mycobacterium avium complex

Indexed keywords

CHLORIDE; CLARITHROMYCIN; ETHAMBUTOL; FIBRILLIN 2; GAMMA INTERFERON RECEPTOR; GENOMIC DNA; RIFABUTIN;

ADULT; AMINO ACID SUBSTITUTION; ANEURYSM; AORTA ROOT; ARACHNODACTYLY; ARTICLE; ATRIAL SEPTAL ANEURYSM; ATYPICAL MYCOBACTERIOSIS; BRONCHIECTASIS; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONGENITAL CONTRACTURAL ARACHNODACTYLY; COUGHING; EXON; EXON 29; FAMILY; FAMILY HISTORY; FEMALE; FEVER; FIBRILLIN 2 GENE; GENE; GENE MUTATION; HEART ATRIUM SEPTUM DEFECT; HETEROZYGOSITY; HUMAN; INFECTION SENSITIVITY; LUNG INFECTION; LUNG LAVAGE; LUNG NODULE; LUNG TUBERCULOSIS; MISSENSE MUTATION; MITRAL VALVE PROLAPSE; MYCOBACTERIUM AVIUM; PEDIGREE ANALYSIS; PNEUMONIA; PRIORITY JOURNAL; SCOLIOSIS; SPUTUM CULTURE; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT RESPONSE; WEIGHT REDUCTION;

FEMALE; HUMANS; LUNG DISEASES; MARFAN SYNDROME; MICROFILAMENT PROTEINS; MIDDLE AGED; MUTATION; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; NONTUBERCULOUS MYCOBACTERIA;

EID: 84858665577     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.11.0301     Document Type: Article

References (10)

1. Anderson R A, Koch S, Camerini-Otero R D. Cardiovascular findings in congenital contractural arachnodactyly: report of an affected kindred. Am J Med Genet 1984; 18: 265-271. (Pubitemid 14124901)
2. Callewaert B L, Loeys B L, Ficcadenti A, et al. Comprehensive clinical and molecular assessment of 32 probands with congenital contractural arachnodactyly: report of 14 novel mutations and review of the literature. Hum Mutat 2009; 30: 334-341.
3. Frédéric M Y, Monino C, Marschall C, et al. The FBN2 gene: new mutations, locus-specific database (Universal Mutation Database FBN2), and genotype-phenotype correlations. Hum Mutat 2009; 30: 181-190.
4. Neptune E R, Frischmeyer P A, Arking D E, et al. Dysregulation of TGF-β activation contributes to pathogenesis in Marfan syndrome. Nat Genet 2003; 33: 407-411. (Pubitemid 36278859)
5. Zhang H, Hu W, Ramirez F. Developmental expression of fibrillin genes suggests heterogeneity of extracellular microfibrils. J Cell Biol 1995; 129: 1165-1176.
6. Arteaga-Solis E, Gayraud B, Lee S Y, Shum L, Sakai L, Ramirez F. Regulation of limb patterning by extracellular microfibrils. J Cell Biol 2001; 154: 275-281. (Pubitemid 34286139)
7. Yang Q, Ota K, Tian Y, et al. Cloning of rat fibrillin-2 cDNA and its role in branching morphogenesis of embryonic lung. Dev Biol 1999; 212: 229-242. (Pubitemid 29368349)
8. Wood J R, Bellamy D, Child A H, Citron K M. Pulmonary disease in patients with Marfan syndrome. Thorax 1984; 39: 780-784. (Pubitemid 14038832)
9. Kim R D, Greenberg D E, Ehrmantraut M E, et al. Pulmonary non-tuberculous mycobacterial disease: prospective study of morphotype, laboratory and genetic features of a distinct syndrome. Am J Respir Crit Care Med 2008; 178: 1066-1074.
10. Colombo R E, Hill S C, Claypool R J, Holland S M, Olivier K N. Familial clustering of pulmonary non-tuberculous mycobacterial disease. Chest 2010; 137: 629-634.